Health Care

It May Sound Awful, but We Really Do Need to Pay for Human Organs

By Marc Joffe

With dialysis being so expensive, onerous and ultimately fatal, kidney patients and taxpayers would be better off with more donations.
Feds' Big Bust: $1.3 Billion Health Insurance Fraud Takedown

By Rob Garver

On the same day that Republican members of the Senate released a pair of bills aimed at repealing and replacing the Affordable Care Act, the Department of Justice highlighted a problem with the...
Where Do You Store Your Medical Info? Apple Wants It to Be Your iPhone

By Christina Farr, CNBC

Imagine turning to your iPhone for all your health and medical information — every doctor's visit, lab test result, prescription and other health information, all available in a snapshot on your...
How American Health Care Became a Big, Broken Business

By Yuval Rosenberg

Who’s to blame for the sad state of the American health care system in 2017? The short answer, as Dr. Elisabeth Rosenthal details in her new book “An American Sickness: How Healthcare Became Big...
Why You Should Think Twice Before Drinking That Can of Soda

By Barbara Moran

New research suggests that excess sugar—especially the fructose in sugary drinks—might damage your brain.

One Major Obamacare Insurance Company Is Close to Break Even This Year

By Eric Pianin

Despite high premiums and diminished consumer choices that might deter consumers from enrolling in Obamacare, a new financial analysis concludes that the individual health insurance market has shaken...
New Cancer Drugs Show Promise – and Sky-High Prices

By DEENA BEASLEY, Reuters

Newer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that can now top $250,000 a year. The drugs' success...
The Billion Dollar Drug for Opioid Victims Has a Problem: It’s Addictive

By Andrew L Yarrow

Maryland Gov. Larry Hogan’s executive order earlier this month, declaring the state’s opioid addiction crisis a state of emergency, is yet another example of the state’s leadership in addressing a...
Pfizer Chief Says Government Efforts to Contain Drug Prices Will Backfire

By Eric Pianin

Ian C. Read, Pfizer’s hard-edged, Scottish-born CEO and chairman, has been unapologetic about his company’s dubious pricing practices. Last week, he gave no ground on the larger question about...
Trump’s Big Cuts to Medical Research May Not Get Past Congress

By Eric Pianin

NIH, Donald Trump, Paul Ryan, Joe Biden, cancer research, National Institutes of Health

New Tech Tools Beat the High Cost of Prescription Drugs

By Eric Pianin

For those in the market for a drug to lower their cholesterol, here’s some useful news: A 30-day supply of Atorvastatin – a generic version of Lipitor -- is going for $10.50 on line at Health...
Budget-Strapped States Are Rationing Hepatitis-C Drug Treatment

By Eric Pianin

Under the staggering cost of providing a state of the art drug to combat the deadly Hepatitis-C virus, as many as three fifths of state Medicaid programs have imposed tough restrictions on millions...
Big Pharma Prepares Ad Blitz to Improve Its Tainted Image

By Eric Pianin

Last week’s House Oversight and Government Reform Committee hearing on predatory prescription drug pricing didn’t offer much insight into the pharmaceutical industry’s controversial research and...
Why 'Bad Boy' Martin Shkreli Has Been a Godsend for the Drug Industry

By David Dayen

Many argue that the bad-boy spectacle known as Martin Shkreli, the former Turing Pharmaceuticals CEO, has deeply damaged drug companies’ reputations. I would counter that he’s been more of a godsend...
Disgraced Pharma Exec Shkreli Smirks His Way Through Drug Price Hearing

By Rob Garver

Under indictment by the Justice Department for securities fraud and by the general public for predatory drug pricing, former Turing Pharmaceutical CEO Martin Shkreli smirked his way through a hearing...

Search form